Department of Endocrinology and Metabolism, Shanghai Jiao Tong University Affiliated Sixth People's Hospital; Shanghai Diabetes Institute; Shanghai Clinical Center for Diabetes; Shanghai key Laboratory of Diabetes Mellitus, 600 Yishan Road, Shanghai 200233, China.
Department of VIP, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, 600 Yishan Road, Shanghai 200233, China.
Diabetol Metab Syndr. 2014 Jun 3;6:71. doi: 10.1186/1758-5996-6-71. eCollection 2014.
The clinical features of atherosclerotic lesions in ketosis-onset diabetes are largely absent. We aimed to compare the characteristics of lower limb atherosclerotic lesions among type 1, ketosis-onset and non-ketotic type 2 diabetes.
A cross-sectional study was performed in newly diagnosed Chinese patients with diabetes, including 53 type 1 diabetics with positive islet-associated autoantibodies, 208 ketosis-onset diabetics without islet-associated autoantibodies, and 215 non-ketotic type 2 diabetics. Sixty-two subjects without diabetes were used as control. Femoral intima-media thickness (FIMT), lower limb atherosclerotic plaque and stenosis were evaluated and compared among the four groups based on ultrasonography. The risk factors associated with lower limb atherosclerotic plaque were evaluated via binary logistic regression in patients with diabetes.
After adjusting for age and sex, the prevalence of lower limb plaque in the patients with ketosis-onset diabetes (47.6%) was significantly higher than in the control subjects (25.8%, p = 0.013), and showed a higher trend compared with the patients with type 1 diabetes (39.6%, p = 0.072), but no difference was observed in comparison to the patients with non-ketotic type 2 diabetes (62.3%, p = 0.859). The mean FIMT in the ketosis-onset diabetics (0.73 ± 0.17 mm) was markedly greater than that in the control subjects (0.69 ± 0.13 mm, p = 0.045) after controlling for age and sex, but no significant differences were found between the ketosis-onset diabetics and the type 1 diabetics (0.71 ± 0.16 mm, p = 0.373), and the non-ketotic type 2 diabetics (0.80 ± 0.22 mm, p = 0.280), respectively. Age and FIMT were independent risk factors for the presence of lower limb plaque in both the ketosis-onset and non-ketotic type 2 diabetic patients, while sex and age in the type 1 diabetic patients.
The prevalence and risk of lower limb atherosclerotic plaque in the ketosis-onset diabetes were remarkably higher than in the control subjects without diabetes. The features and risk factors of lower limb atherosclerotic lesions in the ketosis-onset diabetes resembled those in the non-ketotic type 2 diabetes, but different from those in the type 1 diabetes. Our findings provide further evidences to support the classification of ketosis-onset diabetes as a subtype of type 2 diabetes rather than idiopathic type 1 diabetes.
酮症起病糖尿病患者的动脉粥样硬化病变的临床特征在很大程度上缺失。我们旨在比较 1 型、酮症起病和非酮症 2 型糖尿病患者下肢动脉粥样硬化病变的特征。
对新诊断的中国糖尿病患者进行横断面研究,包括 53 例胰岛相关自身抗体阳性的 1 型糖尿病患者、208 例无胰岛相关自身抗体的酮症起病糖尿病患者和 215 例非酮症 2 型糖尿病患者。62 名无糖尿病的受试者作为对照组。根据超声检查评估并比较四组人群的股内中膜厚度(FIMT)、下肢粥样硬化斑块和狭窄。通过二元逻辑回归评估糖尿病患者下肢粥样硬化斑块的相关危险因素。
调整年龄和性别后,酮症起病糖尿病患者(47.6%)下肢斑块的患病率明显高于对照组(25.8%,p=0.013),且呈上升趋势与 1 型糖尿病患者(39.6%,p=0.072)相比,但与非酮症 2 型糖尿病患者(62.3%,p=0.859)无差异。酮症起病糖尿病患者的平均 FIMT(0.73±0.17mm)明显大于对照组(0.69±0.13mm,p=0.045),但与 1 型糖尿病患者(0.71±0.16mm,p=0.373)和非酮症 2 型糖尿病患者(0.80±0.22mm,p=0.280)无显著差异。年龄和 FIMT 是酮症起病和非酮症 2 型糖尿病患者下肢斑块存在的独立危险因素,而性别和年龄是 1 型糖尿病患者的独立危险因素。
酮症起病糖尿病患者下肢动脉粥样硬化斑块的患病率和风险明显高于无糖尿病的对照组。酮症起病糖尿病患者下肢动脉粥样硬化病变的特征和危险因素与非酮症 2 型糖尿病相似,但与 1 型糖尿病不同。我们的研究结果为将酮症起病糖尿病归类为 2 型糖尿病的一种亚型而不是特发性 1 型糖尿病提供了进一步的证据。